JournalTOCs

Urology Times
Journal Prestige (SJR): 0.1

Number of Followers: 3

Free journal
ISSN (Print) 0093-9722
Published by ModernMedicine

[1 journal]

Dr. Nitin Yerram on a 3D modeling tool for pre-operative surgical planning
- Abstract: “We believe this is going to be the next rendition of how we can train physicians, as well as make surgeons more effective at their job,” says Nitin K. Yerram, MD.
  PubDate: Fri, 09 Aug 2024 18:30:35 +000
Novel classification system proposed for Peyronie disease, penile
curvature
- Abstract: "We propose a new classification system, which we believe will provide a more consistent and standardized approach to classification and treatment of PD," says Landon Trost, MD.
  PubDate: Fri, 09 Aug 2024 18:10:08 +000
Research focuses on identifying targets for overactive bladder treatment
- Abstract: "If we want to do a targeted therapy, we have to know exactly where and what we are treating," says Gamal M. Ghoniem, MD, FACS, ABU/FPMRS.
  PubDate: Fri, 09 Aug 2024 14:57:41 +000
Motolani Adedipe, PhD, on a mobile app for Black men with prostate cancer
- Abstract: "By helping them see what could be going on with their health and knowing when to reach out for help, we think that's a fantastic way to begin to change the paradigm when it comes to men and prostate cancer in the US," says Motolani Adedipe, PhD, DPh, MSc.
  PubDate: Fri, 09 Aug 2024 14:55:45 +000
Challenges of PSA as a Diagnostic Biomarker
- Abstract: The key opinion leaders explore the challenges and limitations associated with using prostate-specific antigen (PSA) as a biomarker for prostate cancer detection and monitoring.
  PubDate: Fri, 09 Aug 2024 14:48:07 +000
Overview of Prostate Cancer
- Abstract: The panel of experts in prostate cancer offers a comprehensive overview of prostate cancer diagnosis, emphasizing the role of prostate-specific antigen (PSA) testing in screening for the disease.
  PubDate: Fri, 09 Aug 2024 14:18:19 +000
John Michael DiBianco, MD, on impact of miniPCNL in pediatric patients
- Abstract: "The cases that I've done have been here, at least, have been some of the most, I guess, impactful and really make me proud and happy to be a urologist and to do something [for which] the patients are incredibly grateful," says John Michael DiBianco, MD.
  PubDate: Fri, 09 Aug 2024 13:55:32 +000
Same-day discharge after robotic prostatectomy shows low uptake in
Michigan
- Abstract: "We did see a rise in 2020, and that's been kind of maintained in 2021 and 2022, but overall, it looked like a pretty low rate," says Brian R. Lane, MD, PhD, FACS.
  PubDate: Thu, 08 Aug 2024 20:08:44 +000
Study compares imaging methods for MDT in oligorecurrent prostate cancer
- Abstract: The median PFS with PSMA PET/CT-guided MDT was 33.2 months, vs 13.8 months with choline PET/CT-guided MDT.
  PubDate: Thu, 08 Aug 2024 18:55:01 +000
Joel Gelman, MD, on teaching urethral stricture surgery internationally
- Abstract: "My goal in the trip was not to see how many patients I could operate on, how many doctors I could train, [it was] to help 1 person train," says Joel Gelman, MD.
  PubDate: Thu, 08 Aug 2024 17:27:31 +000
Dr. Rust recaps the SMSNA Men’s Health Fellowship Bootcamp
- Abstract: “We get exposure and get an opportunity to work with experts in the field before we even start fellowship, so that we can develop a baseline of expertise in areas of Peyronie's disease, erectile dysfunction, infertility, and managing sexual medicine and fertility in men across the board,” says Jacob Rust, MD.
  PubDate: Thu, 08 Aug 2024 15:40:10 +000
Stockholm3 shows benefit in detecting prostate cancer across ethnicities
- Abstract: Data from the study showed that 45% of biopsies with benign results or low-grade cancers could be reduced overall by using Stockholm3 compared with PSA.
  PubDate: Thu, 08 Aug 2024 14:20:00 +000
Urology trainee burnout and strategies to mitigate it, with Andrew M.
Harris, MD
- Abstract: "If we don't take the time to speak to trainees, an already vulnerable population, we're missing an opportunity to help them early," says Andrew M. Harris, MD.
  PubDate: Wed, 07 Aug 2024 20:20:58 +000
Dr. Gressler on postop opioid prescribing after urology procedures
- Abstract: "A surprise finding was the increase in opioid fulfillment beyond the 7-day postoperative period, which was really unexpected," says Laura Gressler, MS, PhD.
  PubDate: Wed, 07 Aug 2024 20:16:54 +000
Dr. Das on the impact of the new overactive bladder guideline on his
practice
- Abstract: "I think it really is going to change my practice," says Akhil Das, MD, FACS.
  PubDate: Wed, 07 Aug 2024 18:33:27 +000
EMBARK Study: ADT in Nonmetastatic Castration-Sensitive Prostate Cancer
- Abstract: Stephen Freedland, MD, reviews findings from the EMBARK study, which investigated enzalutamide in patients with nonmetastatic castration-sensitive prostate cancer.
  PubDate: Wed, 07 Aug 2024 18:28:41 +000
The Role of ADT in Localized or Locally Advanced Prostate Cancer
- Abstract: 3. Terence Friedlander, MD, provides clinical insights on factors that inform the role for androgen deprivation therapy in the treatment of patients with localized or locally advanced prostate cancer.
  PubDate: Wed, 07 Aug 2024 18:24:29 +000
Dr. Cary details the history of IU’s testicular cancer program
- Abstract: “Fortunately, the chemotherapy regimens that Dr. Einhorn put together in combination with the surgical approaches with Dr. Donohue really revolutionized the cure rates and the care for men with testicular cancer,” says Clint Cary, MD, MPH, MBA.
  PubDate: Wed, 07 Aug 2024 16:15:29 +000
Upfront MRI may help predict aggressive disease in intermediate-risk
prostate cancer
- Abstract: “Our data suggest that an MRI can show suspicious lesions based on size and markers of tumor aggression, which may help doctors differentiate a treatment path for these patients," says Kiran R. Nandalur, MD.
  PubDate: Wed, 07 Aug 2024 14:55:44 +000
Therapies Beyond BCG: FDA-Approved and Emerging Options
- Abstract: Experts discuss available therapies beyond BCG.
  PubDate: Tue, 06 Aug 2024 21:44:06 +000
Recurrence and BCG Resistance in High-Risk NMIBC
- Abstract: Experts discuss the rate of recurrence following first-line BCG therapy.
  PubDate: Tue, 06 Aug 2024 21:36:19 +000
Thriving in Urology: Dr. Kaplan on how he divides clinical and nonclinical
time
- Abstract: "It's the creating of things for me that drives me. Even my wife tells me, 'You are most happy when you're creating new things,' " says Steven A. Kaplan, MD.
  PubDate: Tue, 06 Aug 2024 18:52:09 +000
TikTok Videos About Urogynecologic Conditions: Yale Study Shows
Misinformation Gets More Engagement
- Abstract: “It’s important to realize that a single TikTok post can reach tens of thousands of people and potentially influence health care decisions," says Leslie Rickey, MD, MPH.
  PubDate: Tue, 06 Aug 2024 18:50:30 +000
Investigators link genomic and clinical data to real-world outcomes in
prostate cancer
- Abstract: "The scale of that linkage and the manner with which we were able to do it is really exciting and opens the door for a lot of future discovery," says Michael S. Leapman, MD, MHS.
  PubDate: Tue, 06 Aug 2024 18:40:57 +000
Dr. Helen Bernie highlights recent men’s health initiatives at
Indiana University
- Abstract: “It's been exciting to be on the forefront of new technology and new implants to help men regain their sexual function and empower them,” says Dr. Helen L. Bernie, DO, MPH.
  PubDate: Tue, 06 Aug 2024 16:45:41 +000
Prostate cancer polygenic risk scores evaluated in large data sets
- Abstract: "When it came down to linking the clinical information with both biopsy reports as well as the prostatectomy pathology reports, we didn't have much of a challenge with that," says Randy A. Vince Jr, MD, MS.
  PubDate: Tue, 06 Aug 2024 15:11:21 +000
ArteraAI test expands to inform decisions for active surveillance in
prostate cancer
- Abstract: The prognostic test has now been validated in patients who have undergone active surveillance, radiation therapy, or had a radical prostatectomy.
  PubDate: Tue, 06 Aug 2024 15:00:40 +000
FDA grants rare pediatric disease designation to META-001-PH for primary
hyperoxaluria
- Abstract: In preclinical studies, META-001-PH demonstrated the ability to reduce urinary oxalate excretion by up to 80%.
  PubDate: Mon, 05 Aug 2024 18:45:52 +000
Dr. Meddings on catheterizing for urinary retention
- Abstract: "Unless there's an anatomic reason why you can't use a bladder scanner reliably, then, really you should be using a bladder scanner," says Jennifer Ann Meddings, MD, MSc.
  PubDate: Mon, 05 Aug 2024 16:27:12 +000
FDA requests additional data for TLX250-CDx in kidney cancer
- Abstract: Telix must resubmit the BLA with remediations in order to advance the application to full review, which the company expects to be able to complete within approximately 90 days.
  PubDate: Mon, 05 Aug 2024 15:45:34 +000

HOME > Browse the 73 Subjects covered by JournalTOCs
Subject	Total Journals